PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer

Antibodies targeting the immune checkpoint inhibitor, programmed cell death 1 (PD-1), have provided a breakthrough in the treatment of lung cancer. However, the function of PD-1 in natural killer (NK) cells of cancer patients remains unclear. Herein, we analyzed the expression of PD-1 on the NK cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chao, Li, Min, Zhu, Shan, Chen, Yongchong, Zhou, Lei, Xu, Dongsheng, Xu, Jianting, Li, Zhaozhi, Li, Wei, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415385/
https://www.ncbi.nlm.nih.gov/pubmed/32788875
http://dx.doi.org/10.7150/ijms.47701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415385/
https://www.ncbi.nlm.nih.gov/pubmed/32788875
http://dx.doi.org/10.7150/ijms.47701

Ejemplares similares